cmAngio® vs Rapid PE Triage and Notification (PETN)
AI Verdict
Choose cmAngio® if…
Choose cmAngio if your institution aims to leverage existing mammography screenings for proactive cardiovascular risk assessment in women. This tool is ideal for integrating AI-powered detection of Breast Arterial Calcifications (BAC) into routine breast imaging workflows, providing valuable insights for early intervention and improved patient outcomes related to heart health.
View cmAngio® →Choose Rapid PE Triage and Notification (PETN) if…
Choose Rapid PE Triage and Notification if your emergency department or critical care unit requires rapid, AI-driven identification and notification of suspected central pulmonary embolisms from CTPA scans. This solution is best suited for accelerating time-sensitive PE care pathways, enabling quicker clinical response and improving patient management in acute settings.
View Rapid PE Triage and Notification (PETN) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | cmAngio® | Rapid PE Triage and Notification (PETN) |
|---|---|---|
| Pricing | Paid, out-of-pocket | Contact for pricing |
| Deployment | Cloud-based, integrates with any DICOM-compliant viewer | On-premise Rapid Server (dedicated or virtual) within hospital LAN/firewall, or Rapid Edge Cloud Platform. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Rapid PE Triage and Notification (PETN)Tool B offers real-time notifications to multiple platforms, including PACS, email, and a mobile app, alongside mobile and desktop access, which directly enhances immediate clinical usability and workflow efficiency for time-sensitive conditions. While Tool A emphasizes quick installation and DICOM compatibility, Tool B's direct clinician engagement features are more impactful for day-to-day use.
Clinical Value
Rapid PE Triage and Notification (PETN)Both tools offer significant clinical value by addressing important health concerns with FDA-cleared AI. However, Tool B's focus on rapidly identifying and triaging a life-threatening acute condition like pulmonary embolism, directly accelerating critical care pathways, gives it a slight edge in terms of immediate, high-impact clinical urgency.
Pricing & Value
TieBoth tools lack transparent public pricing, requiring direct contact with the vendor for details. Without specific cost information or detailed value propositions, it is impossible to definitively compare their pricing and overall value.
Enterprise Readiness
Rapid PE Triage and Notification (PETN)Tool B explicitly confirms the availability of a Business Associate Agreement (BAA) and offers flexible deployment options, including both on-premise and cloud, which caters to a wider range of enterprise IT infrastructures and security preferences. While Tool A mentions HIPAA compliance and cybersecurity, its BAA status requires contacting the vendor, making Tool B's readiness more explicitly stated.
Innovation
cmAngio®Tool A demonstrates a slightly higher degree of innovation by extracting novel cardiovascular risk insights from routine mammography, effectively repurposing existing diagnostic data for a secondary, yet significant, health assessment. This extends the utility of a common screening procedure beyond its primary purpose.
Support & Docs
Rapid PE Triage and Notification (PETN)RapidAI clearly outlines its robust support structure, including 24/7/365 availability and dedicated resources like a Help Center and documentation. This level of explicit detail and commitment to continuous support is a stronger indicator of comprehensive support compared to the general contact information provided by CureMetrix.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | cmAngio® | Rapid PE Triage and Notification (PETN) |
|---|---|---|
| Name | cmAngiou00ae | Rapid PE Triage and Notification (PETN) |
| Company | CureMetrix | RapidAI (formerly iSchemaView) |
| Primary Detection Target | Breast Arterial Calcifications (BAC) on mammograms | Suspected central pulmonary embolisms (PE) on CTPA images |
| Key Feature (Specific) | AI-based detection of Breast Arterial Calcifications (BAC); Processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams | AI/ML module for CTPA image analysis; Detection of suspected central pulmonary embolism (PE); Real-time notifications to clinicians |
| Specialties | Cardiology, Obstetrics & Gynecology, Radiology | Cardiology, Emergency Medicine, Radiology |
Videos
Demos, reviews, and walkthroughs featuring cmAngio® and Rapid PE Triage and Notification (PETN).